Introduction
The use of human fetal tissue for research purposes is a subject which arouses strong feelings. Although there is no doubt that scientific research using fetal tissue has enormous potential, different governments impose very different restrictions on its use (for review see British Medical_Journal (1). In the UK an advisory group was asked in 1970 'to consider the ethical, medical, social and legal implications of using fetuses and fetal material for research'. The resulting Peel Report, published in 1972 (2), recommended that research should be allowed on fetuses weighing less than 300g, provided there was no objection on the part of the mother and the
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In the late 1980s, concerned principally about experiments in which human fetal tissue was being grafted into the brains of patients suffering from Parkinsonism, the British government invited a second committee, led by the Reverend Dr John Polkinghorne, to review Peel's guidelines. The Polkinghorne Committee took advice from organisations involved in medical research and in the provision of abortion services and also from a significant number of religious organisations and groups campaigning against abortion. The recommendations of the committee were published in 1989 (3) and accepted by the Department of Health in 1990. One of the principal concerns of the committee and of opponents of fetal tissue research was that women might be pressurised into terminating a pregnancy in order to provide fetal material. To 
Practicalities of research
Less than half of the women felt that abortions should be especially timed to allow research to take place. However, once again women about to undergo an abortion were more likely to feel this would be acceptable (41 per cent v 27 per cent, p<0-001). Few of the women felt their decision to allow research on their fetus would be affected if either they (8 per cent) or their fetus (7 per cent) had to be tested for HIV infection. Only 45 per cent of women felt they would be more likely to take part in research were it likely to produce information which might be of direct relevance to them as individuals (for example, the discovery of an inherited disease).
Discussion
In the introduction to the Polkinghorne Report the authors stated that 'it is evident to us that there is much concern over any use of fetal tissue, whether it is described as research or therapy'. The women who took part in this study did not appear to show much concern -94 per cent of them believe there is nothing wrong with research using fetal tissue. They made little if any distinction between pure research and that which had obvious clinical relevance, including the use of fetal tissue for treating adult diseases. It must be remembered that the bulk of research uses tissue obtained after the abortion when the fetus is already dead. The women -particularly those not pregnant at the time -were less likely to approve of research involving a fetus which was still alive, perhaps out of some concern for the moral status of the unborn child, albeit a child destined to die.
Although it is possible that the women may have responded differently had they been asked to donate fetal tissue, we did try to approach this question by distinguishing between approving of research in principle and allowing tissue from their own fetus to be used. For each type of research no more than 2 per cent of the women felt unable to offer their own fetus for research which they had approved in principle. Moreover, the women who were about to have an abortion were more likely to approve of all types of fetal research and to offer their own fetus for use -at least in theory. The women about to undergo an abortion were younger and less likely to have had children than the women in the other group and 41 per cent of them had had an abortion before. It is possible therefore that they had less regard for the unborn child; alternatively they may have agreed with the idea of research using fetal tissue because they felt relieved of some of the anxiety associated with an unwanted pregnancy and received some comfort from the idea that a fetus which they did not want might be put to good use. Whatever the reasons for their overwhelming approval these are the very women that Polkinghome thought might be pressurised into participating in research of which they did not approve.
In an attempt to reduce any possibility of pregnant women being exploited, Polkinghome recommended that the source of fetal tissue and the user should be separated and suggested that the best way to achieve this separation was to involve an intermediary. However, the separation of source and user imposes constraints on the design of certain types of research which could be directly beneficial to women of reproductive age and their babies. For example, research on the effects of corticosteroids on the maturation of the fetal lung would require careful timing of the abortion procedure and would therefore involve the source. Most of the women in our study did not feel it was necessary to separate the doctor who was counselling or treating them from the person who was doing the research. The decision to have a pregnancy terminated is almost always made before a woman reaches a gynaecologist (the potential 'source'), whose role in the counselling process is to make certain she understands the procedure involved and its attendant risks and that she is absolutely certain of her decision. It seems unlikely to us that a woman would deliberately embark upon a pregnancy in order to have it terminated solely to provide tissue for research purposes, since for the vast majority the decision to have an abortion is painful and difficult and not undertaken lightly. The termination of a pregnancy expressly to provide tissue for research would appear to be already illegal. The 1967 Abortion Act states that two doctors in good faith should have reason to believe that a woman has grounds for having a pregnancy terminated and the permitted grounds do not include terminating a pregnancy in order to provide tissue. If the main concern of the Polkinghorne Report was to prevent an act which was already illegal it seems superfluous. It could be argued that there would be a greater risk of abuse of the existing abortion law by women wishing to provide fetal tissue for treatment of relatives or friends suffering from a disease (for example, Parkinson's) which might thus be alleviated. It would be sufficient to add an amendment to the existing Abortion Act, regulating the circumstances under which fetal tissue could be used for treatment.
Positive explicit consent
The report recommends that 'positive explicit consent' should be obtained from the mothers to the use of the fetus or fetal tissues. However, the information on which she is to base her informed consent has to be general (not 'explicit') because it has to embrace all the potential research. It would not be permissible to give the mother any indication of the exact use, indeed it would be impossible because the doctor who gained her consent to research (the source) is prohibited from communicating in any way with the user. While many of the women we asked agreed to giving general consent, a significant minority (32 per cent) felt they would want some detail about the proposed research and would like the opportunity to ask questions. There seems no reason to deny more specific information to those women who want it. With both the woman and the doctor ignorant of the precise use of the tissue it is hard to imagine circumstances in which consent would be either sought or given.
Notable differences
There are some notable differences between the membership and emphasis of the Peel Committee and the Polkinghorne Committee. The members of the Peel Committee specifically stated that they had tried to maintain a balance between ethical concerns and the important contributions which could be made to medical science and 'to the health and welfare of the entire population' by the use of fetal tissue. In contrast the Polkinghorne Committee did not consider any 'particular contemporary developments' taking place either in society or in science but couched the report purely in terms of ethical principles. The Peel Committee was chaired by a gynaecologist and included, among others, two other doctors, two nurses and a social worker. The membership of the Polkinghome Committee comprised the president of a Cambridge college, the president of an Oxford college (the only medical practitioner -a general physician approaching retirement), a professor of medical law and ethics and a sociologist. In the letter to three secretaries of state which introduces his report, the Rev Dr Polkinghorne wrote that the members of the committee 'brought with them a variety of experience relevant to this inquiry'. While we do not intend to argue the rights or wrongs of the use of fetal tissue for research it seems clear to us that the women whom Polkinghorne was trying to protect feel very differently about the subject than the members of his committee would appear to. It seems odd to us that it was not considered relevant to include on the committee more people who came into direct contact with women faced with an unwanted pregnancy. The very fact that the committee was seeking to make recommendations to protect women from something which gynaecologists consider to be already illegal suggests that the membership might have benefited from the presence of someone actively involved with the provision of abortion. One could even argue that it might have been even more relevant to seek the opinions of women in general and in particular of those women considering having an abortion. This conference represents the culmination of a twoyear research project carried out by the two institutions. The participants in the project came from eight countries in Europe and North America, and focused their work on five major themes: 1) the meaning and significance of old age in contemporary society; 2) the goals of medicine and health care for the elderly; 3) balancing the needs of the young and the old: intergenerational obligations; 4) resource allocation and social priorities, and 5) families, society and long-term care.
Over the two years of the project an intense investigation of these issues was carried out, drawing not only on the knowledge and resources of the project participants but also on that of other appropriate experts. The research group itself was a mixture of geriatricians, gerontologists, ethicists, philosophers, demographers and sociologists.
The planned conference in Maastricht will be focused around the five themes cited above and, at the core of the conference, will be papers prepared by the research project participants. In addition, however, other people who were not part of the project will be asked to make presentations as well, as a result of a call for papers. By virtue of additional participants from developing regions of the world, the conference will extend the scope of the original research to look at resource allocation for the old as a growing world-wide problem.
There is a call for papers on one or more of the general topics cited above, or other issues pertinent to resource allocation and the elderly. Abstracts have to be sent before April 1 to: International Aging Conference, The Hastings Center, 255 Elm Road, Briarcliff Manor, NY 10510, USA.
Please write to The Hastings Center for further information and registration, or phone: 1-914-762-8500 (fax: 1-914-762-2124).
News and notes

Euthanasia and Assisted Suicide in the Netherlands
A conference on how and why medical decisions concerning the end of life developed in the Netherlands the way they did is to be held in Maastricht, the Netherlands, on June 10th and 11th this year.
For more information please contact: The Convenor, Euthanasia and Assisted Suicide in the Netherlands, The Institute for Bioethics, PO Box 778, 6200 AT Maastricht, the Netherlands. Phone: 31-43-217575; fax: 31-43-256373.
